BONE-MARROW TRANSPLANTATION (BMT) FOR WISKOTT-ALDRICH SYNDROME (WAS) - COMPARISON OF UNRELATED DONOR (URD) BMT WITH RESULTS OF BMT USING MATCHED SIBLING DONORS (MSD) AND OTHER RELATED DONORS (ORD)

被引：0
|
作者：
FILIPOVICH, AH
KOLLMAN, C
ROWLINGS, P
HOROWITZ, M
机构：
[1] UNIV MINNESOTA,MINNEAPOLIS,MN 55455
[2] NATL MARROW DONOR PROGRAM,ST PAUL,MN
[3] INT BONE MARROW TRANSPLANT REGISTRY,MILWAUKEE,WI
来源：
EXPERIMENTAL HEMATOLOGY | 1994年 / 22卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：679 / 679
页数：1
相关论文
共 50 条
  • [31] COMPARISON OF IMMUNE RECONSTITUTION IN AUTOLOGOUS PURGED, HAPLOIDENTICAL T-CELL DEPLETED, AND SIBLING MATCHED ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR MALIGNANCY IN CHILDREN
    NELSON, SF
    CHAN, J
    MATTHAY, KK
    WARA, D
    COWAN, M
    PEDIATRIC RESEARCH, 1991, 29 (04) : A161 - A161
  • [32] Equivalent leukemia-free survival (LFS) in children (<18 years) with ALL in second remission (CR2) after bone marrow transplantation (BMT) using sibling-donor or phenotypically-matched unrelated donor (URD).
    Grewal, SS
    Wagner, JE
    Defor, TE
    MacMillan, ML
    Baker, KS
    Orchard, PJ
    Dusenbery, K
    Davies, SM
    Ramsay, NKC
    BLOOD, 2002, 100 (11) : 467B - 467B
  • [33] HLA-DPB AND BONE-MARROW TRANSPLANTATION (BMT) FROM UNRELATED DONORS - EVALUATION OF METHODS USED FOR DPB MATCHING, COMPARISON BETWEEN PCR FINGERPRINTING, OLIGOTYPING AND MIXED LYMPHOCYTE REACTIONS
    MAZZOLA, G
    GALLINO, C
    BERRINO, M
    CORNAGLIA, M
    PASTORI, F
    BARBANTI, M
    ELBORAI, MH
    AMOROSO, A
    HUMAN IMMUNOLOGY, 1993, 36 (01) : 61 - 61
  • [34] Intracellular cytokine induction in T-lymphocyte subsets of bone marrow donors and recipients of autologous, HLA-matched-related (MRD) and matched-unrelated (MUD) bone marrow transplant (BMT) recipients.
    van Esser, JWJ
    Gratama, JW
    Lamers, CHJ
    Cornelissen, JJ
    Bolhuis, RLH
    BONE MARROW TRANSPLANTATION, 1999, 23 : S79 - S79
  • [35] Non-myeloablative bone marrow transplantation (BMT) from HLA-mismatched, related donors using post-transplant cyclophosphamide (CY).
    O'Donnell, PV
    Luznik, L
    Jones, RJ
    Vogelsang, GB
    Leffell, MS
    Phelps, M
    Cowan, K
    Piantadosi, S
    Fuchs, EJ
    BLOOD, 2001, 98 (11) : 671A - 671A
  • [36] Is bone marrow transplantation (BMT) from a matched sibling donor (MSD) still the treatment of first choice in severe aplastic anemia (SAA) in children -: long term follow up of the SAA 94 study
    Führer, M
    Rampf, U
    Niemeyer, C
    Ebell, W
    Friedrich, W
    Bender-Goetze, C
    BONE MARROW TRANSPLANTATION, 2002, 30 : S65 - S66
  • [37] Improved outcome after peripheral blood stem cell (PBSCT) compared to bone marrow transplantation (BMT) from unrelated donors using a uniform GvHD-prophylaxis regimen
    Bertz, H
    Potthoff, K
    Finke, J
    BONE MARROW TRANSPLANTATION, 2002, 29 : S228 - S228
  • [38] DETERMINATION OF MIXED CHIMERISM IN RELATED OR UNRELATED AND SAME OR DIFFERENT SEX MATCHED BONE-MARROW TRANSPLANT (BMT) RECIPIENTS USING PCR FOR VARIABLE NUMBER OF TANDEM REPEATS (VNTR)
    LUM, LG
    UEDA, M
    WING, M
    BITONTI, O
    BLOOD, 1994, 84 (10) : A338 - A338
  • [39] Comparative outcomes of cyclosporine/methotrexate and CD6+T cell depletion (TCD) as graft-vs-host disease (GVHD) prophylaxis for allogeneic bone marrow transplantation (BMT) from unrelated donors (URD).
    Soiffer, RJ
    Weller, E
    Lee, SJ
    Alyea, EP
    Schlossman, RL
    Gribben, JG
    Ritz, J
    Antin, JH
    BLOOD, 2000, 96 (11) : 415A - 415A
  • [40] Comparison of HLA-identical transplantation of unselected blood stem cells (PBSCT) and bone marrow (BMT) from related donors in patients with hematologic malignancy:: A single center report
    Kubel, M
    Leiblein, S
    Pönisch, W
    Schulze, E
    Schwenke, H
    Kamprad, F
    Krahl, R
    BONE MARROW TRANSPLANTATION, 1998, 22 : S27 - S27
12345